• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Biomarin Pharmaceutical

Biomarin Pharmaceutical

  1. All
  2. Morningstar Articles
  3. 3rd Party
  1. UPDATE: Bull trend intact, latest S&P 500 breakout attempt underway

    UPDATE: Bull trend intact, latest S&P 500 breakout attempt underway

  2. UPDATE: Bull trend intact, latest S&P 500 -2-

    UPDATE: Bull trend intact, latest S&P 500 -2-

  3. Bull trend intact, latest S&P 500 breakout -2-

    Bull trend intact, latest S&P 500 breakout -2-

  4. Bull trend intact, latest S&P 500 breakout attempt underway

    Bull trend intact, latest S&P 500 breakout attempt underway

  5. Medivation shareholders should be 'thrilled' about price of Pfizer deal: analysts

    Medivation shareholders should be 'thrilled' about price of Pfizer deal: analysts

  6. Global Alpha-N-Acetylglucosaminidase (N-Acetyl-Alpha-Glucosaminidase or NAG or EC 3.2.1.50) Pipeline Report 2016 - Research and Markets

    Global Alpha-N-Acetylglucosaminidase (N-Acetyl-Alpha-Glucosaminidase or NAG or EC 3.2.1.50) Pipeline Report 2016 - Research and Markets

  7. UPDATE: Bull trend intact, S&P 500 stages garden-variety pullback

    UPDATE: Bull trend intact, S&P 500 stages garden-variety pullback

123
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.